Eye Cancer
11
2
3
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (11)
Suprachoroidal Administration in Subjects With Metastases to the Choroid
Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma
MRI in Diagnosing Solid Tumors of the Eye and Orbit
Vaccine Therapy in Treating Patients With Metastatic Cancer
BCC Excision Revisited
Use of an Allograft Set-up (SclerFIX) as Replacement of Sclera Graft for Support of Enucleation Implant
Study of D-Methadone in Patients With Chronic Pain
B-Receptor Signaling in Cardiomyopathy
Social-Psychological Aspects of Orbital Exenteration
Intra-arterial Chemotherapy for Advanced Intraocular Retinoblastoma
Quality of Life of Eye Amputated Patients in Denmark